Public-registry site landscape for NCT06542497, a Presbyopia study sponsored by Ocuphire Pharma, Inc.. All data below is from public sources; Eichor is not affiliated with the sponsor.
| Trial | NCT06542497 (registry record) |
| Sponsor | Ocuphire Pharma, Inc. |
| Condition(s) | Presbyopia |
| Phase | PHASE3 |
| Listed sites | 39 |
| Site countries | United States |
Eichor generates a preliminary site-risk snapshot for NCT06542497 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →